Next Article in Journal
Vaccine Hesitancy: Contemporary Issues and Historical Background
Next Article in Special Issue
Tixagevimab and Cilgavimab (Evusheld™) Prophylaxis Prevents Breakthrough COVID-19 Infections in Immunosuppressed Population: 6-Month Prospective Study
Previous Article in Journal
Using ELEFIGHT® QR Codes for Quick Access to Information on Influenza Burden and Prevention: A Pilot Study in Lyon University Hospital
Previous Article in Special Issue
COVID-19 Vaccination in Multiple Sclerosis and Inflammatory Diseases: Effects from Disease-Modifying Therapy, Long-Term Seroprevalence and Breakthrough Infections
 
 
Article

Article Versions Notes

Vaccines 2022, 10(10), 1593; https://doi.org/10.3390/vaccines10101593
Action Date Notes Link
article pdf uploaded. 22 September 2022 12:39 CEST Version of Record https://www.mdpi.com/2076-393X/10/10/1593/pdf-vor
article pdf uploaded. 23 September 2022 03:37 CEST Updated version of record https://www.mdpi.com/2076-393X/10/10/1593/pdf-vor
article xml file uploaded 30 September 2022 12:41 CEST Original file -
article xml uploaded. 30 September 2022 12:41 CEST Update https://www.mdpi.com/2076-393X/10/10/1593/xml
article pdf uploaded. 30 September 2022 12:41 CEST Updated version of record https://www.mdpi.com/2076-393X/10/10/1593/pdf
article html file updated 30 September 2022 12:43 CEST Original file -
article html file updated 28 February 2023 14:48 CET Update https://www.mdpi.com/2076-393X/10/10/1593/html
Back to TopTop